Glomerular Diseases: 2024 Update

Online Product

Glomerular medicine is exploding with exciting new understanding of disease pathogenesis, which has led to developments in novel genetic and serological diagnostic tools, clinical trials, and potential treatments. This program explores novel changes in IgAN/Henoch-Schonlein purpura, lupus nephritis, podocytopathies (FSGS/minimal change disease), membranous GN, atypical hemolytic uremic syndrome/C3 glomerulopathy, diabetic kidney disease, glomerular disease as "CKD," and monoclonal gammopathy of renal significance. Hot topics are reviewed, including how and when to use genetics in the diagnosis and treatment of glomerular diseases, chimeric antigen receptor T cell therapy, balancing cost and efficacy of new medications for glomerular diseases, and precision medicine and clinical trials. Experts present cutting-edge clinical applications in treatment, pathology, and genetics that continue to change the diagnostic and therapeutic landscape in glomerular diseases. Please note: no CE credit is available for this On-Demand product.